SCHEDULE: Armistice Capital Discloses 4.99% Stake in Rockwell Medical

Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in Rockwell Medical, Inc., holding 1,808,309 shares of common stock.

Summary

• Armistice Capital, LLC and Steven Boyd collectively reported beneficial ownership of 1,808,309 shares of Rockwell Medical, Inc. common stock.
• This represents 4.99% of the company's outstanding common stock.
• The shares are held with shared voting power and shared dispositive power by both reporting persons.
• Armistice Capital, LLC serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.
• Steven Boyd is the managing member of Armistice Capital, LLC.
• The reporting persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership, indicating a passive investment stake just below the 5% threshold, with no stated intent to influence control.

Positives

• The disclosure of a significant institutional holding by Armistice Capital, LLC and Steven Boyd may signal a level of confidence in Rockwell Medical, Inc.

Negatives

• The filing itself does not contain any negative information regarding Rockwell Medical, Inc.'s operations or financial performance.

Risks

• The filing does not detail specific risks related to Rockwell Medical, Inc.'s operations or financial health, as it is primarily an ownership disclosure.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor holding 4.99% of common stock may provide some level of confidence or market interest in the company.

Key Dates

Keywords

Rockwell Medical, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Healthcare